Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)

Published:2019-11-06 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Yang Pei-Wen,Liu Yu-Cheng,Chang Ya-Han,Lin Ching-Ching,Huang Pei-Ming,Hua Kuo-Tai,Lee Jang-Ming,Hsieh Min-Shu

Funder

Ministry of Science and Technology

National Taiwan University Hospital

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference56 articles.

1. Esophageal carcinoma;Rustgi;N Engl J Med,2014

2. Current management of esophageal cancer;D'Journo;J Thorac Dis,2014

3. Current developments in the management of locally advanced esophageal cancer;McNamara;Curr Oncol Rep,2012

4. Response to preoperative chemotherapy affects prognosis in esophageal cancer;Miyashita;Dis Esophagus,2003

5. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus;Bosset;N Engl J Med.,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disrupting EGFR–HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome;International Journal of Molecular Sciences;2024-05-29

2. Evaluation of the Interactions of Cabozantinib with Topoisomerase Enzymes by in vitro Enzyme Activity Assays, and its Effects on Cancer Cell Proliferation;Cumhuriyet Science Journal;2023-12-28

3. Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target;Frontiers in Oncology;2023-07-04

4. Microfluidic single-cell migration chip reveals insights into the impact of extracellular matrices on cell movement;Lab on a Chip;2023

5. Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation;Genes;2022-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3